Certara Launches BaseCase® Portal™, Enabling Life Sciences Companies to Deliver Therapeutic Decision-making Apps to HCPs at the Point of Care
Summary
PRINCETON, N.J.--( BUSINESS WIRE )--Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today the launch of its BaseCase Portal cloud-based platform, that allows for the rapid creation of fully-customizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients.By creating an intuitive front-end, BaseCase Portal enables clinicians to use complex scientific models and algorithms that were previously only available in research settings, to guide therapeutic decision-making.By wrapping complex algorithms into user-friendly apps, we can make use of a body of science that has been growing for decades but has been largely untapped to improve patient care.Founded in 2007, and acquired by Certara in January 2018, BaseCase is a software as a service (SaaS) and value communication company that has been developing interactive mobile apps for the pharmaceutical and medical device industries for more than a decade.Its clients include hundreds of global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Classifications
AskAI Classifications
LabelsLinked Companies
